128 related articles for article (PubMed ID: 31087330)
1. The performance of cardio-biparietal ratio measured by 2D ultrasound in predicting fetal hemoglobin Bart disease during midpregnancy: A pilot study.
Traisrisilp K; Sirilert S; Tongsong T
Prenat Diagn; 2019 Jul; 39(8):647-651. PubMed ID: 31087330
[TBL] [Abstract][Full Text] [Related]
2. Fetal sonographic cardiothoracic ratio at midpregnancy as a predictor of Hb Bart disease.
Tongsong T; Wanapirak C; Sirichotiyakul S; Piyamongkol W; Chanprapaph P
J Ultrasound Med; 1999 Dec; 18(12):807-11. PubMed ID: 10591443
[TBL] [Abstract][Full Text] [Related]
3. Sonographic markers of hemoglobin Bart disease at midpregnancy.
Tongsong T; Wanapirak C; Sirichotiyakul S; Chanprapaph P
J Ultrasound Med; 2004 Jan; 23(1):49-55. PubMed ID: 14756353
[TBL] [Abstract][Full Text] [Related]
4. Fetal cardiac circumference derived by spatiotemporal image correlation as a predictor of fetal hemoglobin Bart disease at midpregnancy.
Siwawong W; Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Ultrasound Med; 2013 Aug; 32(8):1483-8. PubMed ID: 23887960
[TBL] [Abstract][Full Text] [Related]
5. Screening for hemoglobin Bart's disease among fetuses at risk at mid-pregnancy using the fetal cardiac diameter to biparietal diameter ratio.
Thathan N; Traisrisilp K; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
BMC Pregnancy Childbirth; 2014 Jul; 14():230. PubMed ID: 25028081
[TBL] [Abstract][Full Text] [Related]
6. Fetal Heart Diameter as a Predictor of Hemoglobin Bart Disease at Midpregnancy.
Nattawongsiri C; Tongprasert F; Tongsong T
J Ultrasound Med; 2021 Mar; 40(3):553-557. PubMed ID: 32790107
[TBL] [Abstract][Full Text] [Related]
7. Second trimester maternal serum alpha-fetoprotein (MSAFP) as predictor of fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2014 Dec; 34(13):1277-82. PubMed ID: 25046597
[TBL] [Abstract][Full Text] [Related]
8. High fetal splenic artery peak velocity in fetuses with hemoglobin Bart disease: a preliminary study.
Tongsong T; Tongprasert F; Srisupundit K; Luewan S
J Ultrasound Med; 2009 Jan; 28(1):13-8. PubMed ID: 19106351
[TBL] [Abstract][Full Text] [Related]
9. Identification of fetuses with hemoglobin Bart's disease using middle cerebral artery peak systolic velocity.
Srisupundit K; Piyamongkol W; Tongsong T
Ultrasound Obstet Gynecol; 2009 Jun; 33(6):694-7. PubMed ID: 19350531
[TBL] [Abstract][Full Text] [Related]
10. Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
Prenat Diagn; 2013 Dec; 33(13):1272-5. PubMed ID: 24122800
[TBL] [Abstract][Full Text] [Related]
11. Fetal splenic artery peak velocity (SPA-PSV) at mid-pregnancy as a predictor of Hb Bart's disease.
Tongsong T; Piyamongkol W; Tongprasert F; Srisupundit K; Luewan S
Ultraschall Med; 2011 Jan; 32 Suppl 1():S41-5. PubMed ID: 21225551
[TBL] [Abstract][Full Text] [Related]
12. Appearance of Abnormal Cardiothoracic Ratio of Fetuses with Hemoglobin Bart's Disease: Life Table Analysis.
Wanapirak C; Sirichotiyakul S; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
Ultraschall Med; 2017 Oct; 38(5):544-548. PubMed ID: 28863410
[No Abstract] [Full Text] [Related]
13. Splenic circumference at midpregnancy as a predictor of hemoglobin Bart's disease among fetuses at risk.
Srisupundit K; Tongprasert F; Luewan S; Sirichotiyakul S; Tongsong T
Gynecol Obstet Invest; 2011; 72(1):63-7. PubMed ID: 21389673
[TBL] [Abstract][Full Text] [Related]
14. Second trimester maternal serum inhibin-A in fetal anemia secondary to hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1005-9. PubMed ID: 24107149
[TBL] [Abstract][Full Text] [Related]
15. Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart's fetuses at mid-pregnancy.
Srisupundit K; Piyamongkol W; Tongsong T
Am J Hematol; 2008 Dec; 83(12):908-10. PubMed ID: 18932192
[TBL] [Abstract][Full Text] [Related]
16. Placental thickness at mid-pregnancy as a predictor of Hb Bart's disease.
Tongsong T; Wanapirak C; Sirichotiyakul S
Prenat Diagn; 1999 Nov; 19(11):1027-30. PubMed ID: 10589053
[TBL] [Abstract][Full Text] [Related]
17. Prenatal diagnosis of haemoglobin Bart's disease by cordocentesis at 12-14 weeks--experience with the first 59 cases.
Lam YH; Tang MH
Prenat Diagn; 2000 Nov; 20(11):900-4. PubMed ID: 11113892
[TBL] [Abstract][Full Text] [Related]
18. Fetal liver length measurement at mid-pregnancy among fetuses at risk as a predictor of hemoglobin Bart's disease.
Luewan S; Tongprasert F; Piyamongkol W; Wanapirak C; Tongsong T
J Perinatol; 2011 Mar; 31(3):157-60. PubMed ID: 20651692
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum hCG, PAPP-A and AFP as predictors of hemoglobin Bart disease at mid-pregnancy.
Tongprasert F; Wanapirak C; Tongsong T
Prenat Diagn; 2011 May; 31(5):430-3. PubMed ID: 21312197
[TBL] [Abstract][Full Text] [Related]
20. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease.
Tongprasert F; Srisupundit K; Luewan S; Tongsong T
J Matern Fetal Neonatal Med; 2013 Jan; 26(2):146-9. PubMed ID: 22989193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
